Atectura Breezhaler 150 mcg

Atectura Breezhaler 150 mcg capsules contain indacaterol acetate, a long-acting bronchodilator for inhalation. This medication is designed to help manage chronic obstructive pulmonary disease (COPD) symptoms by improving airflow in the lungs.

Atectura Breezhaler 150 mcg is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles around the airways, making it easier to breathe. This medication is not intended for immediate relief of sudden breathing problems but is used regularly to manage symptoms over time.

Common effects of Atectura Breezhaler 150 mcg may include headache, dizziness, and throat irritation. Some users might experience tremors or palpitations. These effects vary among individuals and are generally mild to moderate in nature.

Atectura Breezhaler 150 mcg should be used as directed by a healthcare provider. It is important to follow the proper inhalation technique to ensure effective delivery of the medication. Patients with certain medical conditions, such as heart disease or severe hypertension, should consult their healthcare provider before use.

Atectura Breezhaler 150 mcg may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.